Laddar...
Renal tuberculosis in an imatinib-treated chronic myeloid leukemia
Imatinib, which inhibits tyrosine kinase activity of Bcr-Abl protein, is a standard form of treatment for chronic myeloid leukemia (CML). Through its immunomodulatory effect it affects T cell function in a number of ways. It inhibits antigen-induced T cell activation and proliferation. Antigen-speci...
Sparad:
| I publikationen: | J Bras Nefrol |
|---|---|
| Huvudupphovsmän: | , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Sociedade Brasileira de Nefrologia
2020
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7657051/ https://ncbi.nlm.nih.gov/pubmed/32353102 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1590/2175-8239-JBN-2019-0123 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|